Aster DM Healthcare, the largest integrated healthcare provider in the Middle East, today signed a Memorandum of Understanding (MoU) with Roche Diagnostics, a world leader in biotechnology, as well as a strategic partner across the United Arab Emirates (UAE), The Kingdom of Saudi Arabia Arabia (KSA), Qatar and Oman. The partnership will enable Aster DM Healthcare's hospitals, clinics, and laboratories across the region to adopt the latest diagnostic innovations and solutions to support their patients with optimal treatment solutions.
Alisha Moopen, Deputy Managing Director at Aster DM Healthcare, said, "At Aster, we are determined to stay ahead of the curve and offer the best medical solutions to our patients and equip our most advanced systems with Roche Diagnostics." In the Middle East underscores our commitment to supporting countries, patients and the medical fraternity across the region by relating the latest healthcare solutions to the prevention, diagnosis, and treatment of various diseases. The early and accurate detection of that can be facilitated by timely medical intervention.